Chemical Structure : SLC-391
Catalog No.: PC-24679Not For Human Use, Lab Use Only.
SLC-391 (SLC-0211) is a potent, selective small molecule inhibitor for AXL with IC50 of 9.6 nM, 4-fold selective over TYRO3 (IC=42.3 nM) and MER (IC50=44 nM).
Bulk size, bulk discount!
Welcome credit card payment!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
SLC-391 (SLC-0211) is a potent, selective small molecule inhibitor for AXL with IC50 of 9.6 nM, 4-fold selective over TYRO3 (IC=42.3 nM) and MER (IC50=44 nM).
SLC-391 demonstrates high selectivity against a panel of 93 individually expressed receptor tyrosine kinases using BaF3 cells.
SLC-391 stabilizes the AXL kinase domain, binds to its active site, and inhibits the growth of AML cells in vitro.
Dual SLC-391 and venetoclax treatment in vivo decreases leukemia burden and enhances survival of mice in 2 aggressive AML models.
Combination treatment with SLC-391 and venetoclax synergistically inhibits proliferation and long-term clonogenic activities of cells from patients with AML in vitro.
Combined treatment with SLC-391 and venetoclax decreases leukemia burden and significantly enhances survival of leukemic mice in a PDX model.
M.Wt | 365.44 | |
Formula | C19H23N7O | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
1. Xiaojia Niu, et al. Blood. 2021 Jul 1;137(26):3641-3655.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright